Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2009
04/16/2009WO2008011130A8 Amide compounds
04/16/2009WO2007069050A3 Processes for the preparation of alfuzosin
04/16/2009WO2006058016A3 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
04/16/2009WO2003082205A3 Compounds and methods
04/16/2009US20090099356 Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction
04/16/2009US20090099241 Pharmaceutical composition containing antihypertensive agents
04/16/2009US20090099236 treatment of depression, anxiety, genitourinary diaorders, pain; monoamine reuptake inhibitors, triple and/or dual reuptake inhibitors of norepinephrine, serotonin, and dopamine; methyl-[3-(3-methyl-1H-indazol-5-yl)-3-phenyl- propyl]-amine
04/16/2009US20090099234 2-pyridinylcycloalkylcarboxamide derivatives as fungicides
04/16/2009US20090099221 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
04/16/2009US20090099220 Antimalarial compounds with flexible side-chains
04/16/2009US20090099219 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
04/16/2009US20090099209 Compounds Useful in Therapy
04/16/2009US20090099201 Diacylglycerol Acyltransferase Inhibitors
04/16/2009US20090099198 Compounds, Compositions and Methods
04/16/2009US20090099183 Pyrimidines and uses thereof
04/16/2009US20090099182 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
04/16/2009US20090099181 Sulfoximines as kinase inhibitors
04/16/2009US20090099180 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
04/16/2009US20090099178 Indazole compounds and methods of use thereof
04/16/2009US20090099176 Pyrrolopyridine-2-carboxylic acid amides
04/16/2009US20090099175 Phosphodiesterase 10 inhibitors
04/16/2009US20090099170 Sirtuin modulating compounds
04/16/2009US20090099160 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors
04/16/2009US20090099158 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor
04/16/2009US20090099156 Heterocyclic Compounds as Ccr2b antagonists
04/16/2009US20090099155 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
04/16/2009US20090099143 Tetrahydro-indazole cannabinoid modulators
04/16/2009US20090099106 Quinoline derivatives for modulating dna methylation
04/16/2009US20090099104 Substituted indazoles-o- glucosides
04/16/2009DE102007049157A1 New substituted 2,3-dihydro-(1,2,3)triazol-4-one compounds are hypoxia inducible factor-prolyl-4-hydroxylase inhibitor, useful for preparing medicament to treat and/or prevent e.g. cardiovascular diseases, inflammatory disease and anemia
04/16/2009DE102007048447A1 New substituted dihydropyrazole-3-thione compounds are hypoxia inducible factor-prolyl-4-hydroxylase inhibitor, useful for preparing medicament to treat and/or prevent e.g. cardiovascular diseases, wound healing and anemia
04/16/2009CA2702265A1 Novel seh inhibitors and their use
04/16/2009CA2702225A1 Diphenyl substituted cycloalkanes
04/16/2009CA2702171A1 Amide compound
04/16/2009CA2702132A1 Spiropyrrolidines and their use against hcv and hiv infection
04/16/2009CA2702008A1 Inhibitors of protein kinases
04/16/2009CA2701932A1 Chiral cis-imidazolines
04/16/2009CA2701839A1 N- (pyrazole-3-yl) -benzamide derivatives as glucokinase activators
04/16/2009CA2701806A1 Pyridine derivatives useful as glucokinase activators
04/16/2009CA2701568A1 Imidazole derivatives
04/16/2009CA2700893A1 Substituted tetrazole compounds and uses thereof
04/16/2009CA2700880A1 Antimalarial compounds with flexible side-chains
04/16/2009CA2699674A1 5-ht7 receptor antagonists
04/15/2009EP2048144A1 Process for the preparation of optically pure omeprazole via salt formation with a chiral amine
04/15/2009EP2048143A1 Prodrug of cinnamide compound
04/15/2009EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
04/15/2009EP2048141A1 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases
04/15/2009EP2048133A1 Nicotinamide n-oxide derivatives as vanilloid-1 receptor modulators
04/15/2009EP2048132A1 Tetrahydro-naphthalene and urea derivatives
04/15/2009EP2046782A2 Imidazolylpyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
04/15/2009EP2046776A2 Methods and apparatus for identifying subject matter in view data
04/15/2009EP2046775A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
04/15/2009EP2046774A1 Pyrazole derivatives as cytochrome p450 inhibitors
04/15/2009EP2046763A2 Aurora kinase inhibitors from an encoded small molecule library
04/15/2009EP2046762A2 Triazolyl phenyl benzenesulfonamides
04/15/2009EP2046761A2 Macrocyclic compounds useful as bace inhibitors
04/15/2009EP2046760A1 Macrocyclic lactams
04/15/2009EP2046758A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
04/15/2009EP2046757A1 Caspase inhibitors based on pyridazinone scaffold
04/15/2009EP2046753A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
04/15/2009EP2046739A1 Substituted aniline derivatives
04/15/2009EP2046292A2 Formulations for benzimidazolyl pyridyl ethers
04/15/2009EP2003130A9 Novel pyridine derivative having anti-helicobacter pylori activity
04/15/2009EP1973896B1 A process for the preparation of the (s)-enantiomer of omeprazole
04/15/2009EP1725235B1 Piperidine derivatives useful as ccr3 antagonists
04/15/2009EP1689720B1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
04/15/2009EP1660091B1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
04/15/2009EP1572686B1 Anthranilic acid amide derivatives and their pharmaceutical use
04/15/2009EP1504001B1 2-(2-pyridyl)-5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi
04/15/2009EP1423115B1 Antiangiogenic activity of nitrogen substituted thalidomide analogs
04/15/2009EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
04/15/2009EP1244648B1 Chemokine receptor binding heterocyclic compounds
04/15/2009EP1154999B1 Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity
04/15/2009EP1043317B1 Pyridazine derivatives and medicaments containing them as active ingredient
04/15/2009CN101410394A HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
04/15/2009CN101410392A Amide substituted quinolines
04/15/2009CN101410391A 2, 3-phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents
04/15/2009CN101410389A Organic compounds
04/15/2009CN101410388A Compounds for the treatment of inflammatory disorders
04/15/2009CN101410387A Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
04/15/2009CN101410380A Nitrogen-containing heterocyclic derivative and organic electroluminescent device using same
04/15/2009CN101410373A Bridged cyanine compounds and optical recording materials containing the same
04/15/2009CN101407496A Method for synthesizing 3,5-disubstituted pyrazole
04/15/2009CN101407495A Preparations and uses of isoquinolinium compounds and salts thereof
04/15/2009CN101407494A Preparations and uses of isoquinolinium compounds and salts thereof
04/15/2009CN101407493A Organic material and use thereof in organic EL device
04/15/2009CN101407492A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same
04/15/2009CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
04/15/2009CN100478340C Pyrrole-2, 5-dithione derivatives as liver X receptor modulators
04/15/2009CN100478339C 5-amido-2-[(4-methoxyl-3-methyl-2-pyridinyl)-methylthio]-1-hydro-benzimidazole and its derivative synthesis method
04/15/2009CN100477992C Substituted piperazine and piperidine calcium channel blockers
04/14/2009US7517998 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
04/14/2009US7517994 Heterocyclic inhibitors of MEK and methods of use thereof
04/14/2009US7517992 (-)-cis-1-(5-(4-fluorophenoxy)-pyridin-2-yl)-3-(4,7-difluoro-1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea; improved resistance and pharmacokinetic profile; polymerase inhibitors; potent against virus comprising drug escape mutations
04/14/2009US7517910 Alkoxyphenylpropanoic acid derivatives
04/14/2009US7517900 Pyrazole derivatives as cannabinoid receptor modulators
04/14/2009US7517898 2-tert-Butyl-N,N-diethyl-1-{[1-methylpiperidin-2-yl]methyl}-1H-benzimidazole-5-carboxamide; cannabinoid receptors agonists; analgesic, anticarcinogenic, antiinflammatory, anxiolytic agent; neurodegenerative diseases; gastrointestinal and cardiovascular disorders
04/14/2009US7517894 Endothelial growth factor; angiogenesis inhibitor; antitumor agents; skin disorders; endometriosis; Crohn's disease; leukemia; antiarthritic agents
04/14/2009US7517893 Bichalcophenes and their prodrugs as antiprotozoal agents
04/14/2009US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof